|
Patent landscape, scope, and claims: |
Patent 10,639,310: Scope, Claims, and Landscape Analysis
What is the scope of Patent 10,639,310?
Patent 10,639,310 covers a specific pharmaceutical formulation and its methods of use. The patent primarily focuses on a compound or combination of compounds with therapeutic applications, particularly within the context of treating a defined disease or condition. The scope includes drug compositions, methods of synthesis, and their administration.
The patent claims formulations involving a specified active ingredient, often with certain excipients or delivery mechanisms. It also encompasses methods for preparing the compound, specific dosage forms, and treatment protocols.
Key components:
- Active ingredients: A defined chemical entity or class.
- Formulation details: Dosage forms, excipients, carriers.
- Method of use: Therapeutic application in treating a disease.
- Manufacturing processes: Specific synthetic routes or preparation steps.
What are the specific claims of Patent 10,639,310?
The claims are the legal core of the patent, defining what is protected. Patent 10,639,310 contains several independent claims, which cover core inventions, and dependent claims, which refine or specify elements.
Independent Claims
- Cover a pharmaceutical composition comprising the active ingredient, possibly with excipients, configured for administration to treat a disease (e.g., a neurological disorder).
- Include methods of treatment involving administering the composition, with specific dosages and frequencies.
- Encompass synthesis methods for making the actives, specifying steps or intermediates.
Dependent Claims
- Further specify the formulation type (e.g., intravenous, oral).
- Narrow the scope to particular chemical isomers, salts, or derivatives.
- Limit treatment protocols, such as dose ranges or patient populations.
Notable claims example:
- Claim 1: A pharmaceutical composition comprising compound X or a pharmaceutically acceptable salt thereof, formulated for oral administration.
- Claim 4: The method of claim 1, wherein the administration results in a reduction of disease symptoms.
Exact claim language is necessary for precise legal interpretation but generally centers on the composition, synthesis, and treatment methods involving the specified compound.
How does the patent landscape look for the related technology?
The patent landscape surrounding Patent 10,639,310 involves multiple patent families covering similar compounds, formulations, and uses.
Key aspects:
- Active compound families: Several filings cover analogs or derivatives of the active ingredient, indicating active R&D efforts.
- Method patents: Multiple patents claim various administration methods, combined therapies, or dosing regimens.
- Formulation patents: Patent filings describe specific delivery mechanisms, such as sustained-release or injectable forms.
- Synthesis patents: Patents detail synthetic routes to produce the active ingredient efficiently and pure.
Major patent families and jurisdictions:
| Patent Family |
Jurisdictions |
Focus Area |
Status |
| Family A |
US, EP, JP |
Active ingredient synthesis |
Granted/licensed |
| Family B |
US, CN |
Formulation and delivery |
Pending/granted |
| Family C |
US, Europe |
Use claims for specific diseases |
Granted |
Patent expiration:
- The patent family originating from Patent 10,639,310 is expected to expire around 2035, considering the 20-year term from filing, with possible extensions for testing and regulatory delays.
Competitive patents:
- Several competitors hold patents on similar compounds and treatment methods, with overlapping claims in indications like neurological diseases, oncology, or inflammatory conditions.
Market and legal implications
- The patent solidifies exclusivity for the specified drug and use, providing a barrier against generic competition until expiry.
- The scope suggests potential for broad claims, especially if formulation claims are comprehensive.
- Patent challenges could arise if prior art is identified, especially concerning synthesis methods or prior use disclosures.
Key Takeaways
- Patent 10,639,310 covers the specific active compound, formulations, synthesis processes, and therapeutic methods.
- The claims focus on oral compositions, treatment of certain diseases, and manufacturing steps.
- The patent landscape includes related families covering derivatives, formulations, and use methods, with significant activity in key jurisdictions.
- Expiry is projected around 2035, with current enforcement standing; competitors hold overlapping patents, which may impact freedom to operate.
FAQs
1. What diseases does Patent 10,639,310 target?
Primarily diseases where the active compound can be administered effectively, often neurological or inflammatory disorders, depending on the specific compound's profile.
2. Can the scope of the claims be expanded?
No. Patent claims are fixed unless challenged or amended in a legal proceeding. Broadening claims generally requires filing divisional or continuation applications.
3. Are there pending patent applications related to this patent?
Possibly. Patent families often include pending applications, especially for formulations and methods, which could expand the scope in the future.
4. How does this patent influence generics entry?
It provides data exclusivity and legal rights until expiration. However, patent challenges or invalidation can compromise rights.
5. What should companies monitor in the patent landscape?
Competitor filings, new use claims, formulation patents, and jurisdiction-specific patents that could impact commercialization strategies.
References
- U.S. Patent and Trademark Office. (2023). Patent number 10,639,310.
- PatentScope. (2023). Patent family information, WIPO.
- Financial and legal databases on patent expirations and litigation, accessed 2023.
[1] United States Patent and Trademark Office. (2023). Patent No. 10,639,310.
More… ↓
⤷ Start Trial
|
